A detailed history of Arlington Partners LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Arlington Partners LLC holds 26,680 shares of JNJ stock, worth $3.85 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares
26,680
Previous 21,346 24.99%
Holding current value
$3.85 Million
Previous $3.12 Million 38.6%
% of portfolio
1.79%
Previous 1.65%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$145.48 - $167.38 $775,990 - $892,804
5,334 Added 24.99%
26,680 $4.32 Million
Q2 2024

Aug 01, 2024

BUY
$144.38 - $157.78 $349,832 - $382,300
2,423 Added 12.8%
21,346 $3.12 Million
Q1 2024

Apr 16, 2024

BUY
$155.22 - $162.74 $765,234 - $802,308
4,930 Added 35.23%
18,923 $2.99 Million
Q4 2023

Jan 24, 2024

SELL
$145.6 - $158.88 $700,336 - $764,212
-4,810 Reduced 25.58%
13,993 $2.19 Million
Q3 2023

Oct 24, 2023

BUY
$155.75 - $174.48 $197,491 - $221,240
1,268 Added 7.23%
18,803 $2.93 Million
Q2 2023

Jul 26, 2023

BUY
$154.35 - $166.11 $153,578 - $165,279
995 Added 6.02%
17,535 $2.9 Million
Q1 2023

Apr 26, 2023

SELL
$151.05 - $180.26 $30,512 - $36,412
-202 Reduced 1.21%
16,540 $2.56 Million
Q4 2022

Jan 19, 2023

BUY
$160.2 - $179.79 $18,583 - $20,855
116 Added 0.7%
16,742 $2.96 Million
Q3 2022

Oct 28, 2022

BUY
$161.33 - $179.52 $137,291 - $152,771
851 Added 5.39%
16,626 $2.72 Million
Q2 2022

Jul 25, 2022

SELL
$168.19 - $186.01 $294,332 - $325,517
-1,750 Reduced 9.99%
15,775 $2.8 Million
Q1 2022

Apr 14, 2022

SELL
$158.14 - $179.59 $346,484 - $393,481
-2,191 Reduced 11.11%
17,525 $3.11 Million
Q4 2021

Jan 18, 2022

BUY
$155.93 - $173.01 $203,956 - $226,297
1,308 Added 7.11%
19,716 $3.37 Million
Q3 2021

Oct 15, 2021

BUY
$161.5 - $179.47 $315,894 - $351,043
1,956 Added 11.89%
18,408 $2.97 Million
Q2 2021

Jul 07, 2021

BUY
$159.48 - $171.07 $260,111 - $279,015
1,631 Added 11.0%
16,452 $2.71 Million
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $413,135 - $460,125
2,699 Added 22.27%
14,821 $2.44 Million
Q4 2020

Jan 13, 2021

BUY
$137.11 - $157.38 $293,963 - $337,422
2,144 Added 21.49%
12,122 $1.91 Million
Q3 2020

Oct 15, 2020

BUY
$140.38 - $153.83 $10,247 - $11,229
73 Added 0.74%
9,978 $1.49 Million
Q2 2020

Jul 13, 2020

BUY
$128.81 - $155.51 $137,182 - $165,618
1,065 Added 12.05%
9,905 $1.39 Million
Q1 2020

Apr 13, 2020

BUY
$111.14 - $153.99 $672,397 - $931,639
6,050 Added 216.85%
8,840 $1.16 Million
Q4 2019

Jan 16, 2020

BUY
$127.5 - $146.44 $10,200 - $11,715
80 Added 2.95%
2,790 $407,000
Q3 2019

Oct 18, 2019

SELL
$126.95 - $142.14 $758,653 - $849,428
-5,976 Reduced 68.8%
2,710 $351,000
Q2 2019

Jul 10, 2019

BUY
$131.15 - $144.24 $816,539 - $898,038
6,226 Added 253.09%
8,686 $1.21 Million
Q1 2019

Apr 05, 2019

SELL
$125.72 - $139.79 $746,776 - $830,352
-5,940 Reduced 70.71%
2,460 $344,000
Q4 2018

Jan 10, 2019

BUY
$122.84 - $147.84 $30,095 - $36,220
245 Added 3.0%
8,400 $1.08 Million
Q2 2018

Jul 11, 2018

SELL
$119.4 - $131.76 $1,671 - $1,844
-14 Reduced 0.17%
8,155 $990,000
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $101,831 - $120,585
814 Added 11.07%
8,169 $1.05 Million
Q4 2017

Jan 29, 2018

BUY
$131.22 - $143.62 $965,123 - $1.06 Million
7,355
7,355 $1.03 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Arlington Partners LLC Portfolio

Follow Arlington Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.